Prospective, Randomised, DBPC Clinical Trial to Evaluate the Efficacy and Safety of Polymerized and Mannan Conjugated Allergen Extract of Dermatophagoides for the Treatment of Allergic Rhinitis/Rhinoconjunctivitis With or Without Asthma
Latest Information Update: 26 Oct 2023
At a glance
- Drugs MM 09 (Primary)
- Indications Allergic rhinitis; Asthma; Rhinoconjunctivitis
- Focus Therapeutic Use
- Acronyms MM09-SLIM
- Sponsors Inmunotek
Most Recent Events
- 20 Oct 2023 Planned End Date changed from 1 Dec 2025 to 1 Dec 2026.
- 20 Oct 2023 Planned primary completion date changed from 1 Jun 2025 to 1 Jun 2026.
- 20 Oct 2023 Planned initiation date changed from 1 Apr 2023 to 1 Nov 2023.